INTRODUCTION Heart failure is a gro...

INTRODUCTION

Heart failure is a growing public health freight with approximately 5 million race afflicted in the United States alone.1 This clinical syndrome accounts for 900000 hospitalizations each year, with an additional 500000 the public diagnosed with heart failure each year.1 According to the American Heart Association (AHA),1 the total inpatient and outpatient health care outlays for this population exceeded $381 billion dollars in 1991

Heart failure is a entangled syndrome that affects multiple organ combination of parts to form a wholes and has a great impact forward the lifestyle of patients. There are many different processs to objectively assess the functional status of patients with heart failure so as the New York Heart Association Classification (NYHA), clinical exercise testing, and self-reported function. Quantifying the impact of this chronic disease onward a patient's lifestyle requires the use of self-reported measures, similar as a health-related quality of life instrument.

Health related quality of life is a multidimensional conception that encompasses domains such as physical, emotional, functional, social, and overall well being. Quality of life (QOL) measures are categorized into generic and disease specific measures. Generic measures can be applied to a wide variety of patient populations and are helpful when comparing different disease processe A generic measure that has been used in the heart failure population is the Medical issues Study Short Form-36 (SF-36), which veils the complete spectrum of health related quality of life. More commonly utilized are the cardiac disease-specific QOL measures as they are more responsive in capturing changes in specific heart failure symptoms, like as dyspnea and fatigue. usual cardiac disease-specific QOL measures include the Chronic Heart Failure Questionnaire (CHQ) the Minnesota Living With Heart Failure Questionnaire (LiHFe), and the Kansas City Cardiomyopathy Questionnaire (KCCQ)

To determine which of the available QOL tools to use, clinicians should consider the time to total the tool, availability of aggregate scoring, splendor and scoring complexity, and psychometric properties of the measures. If time is not a factor, it is make acceptableed to use both a disease-specific and generic tool to provide a comprehensive assessment of QOL2 Table 1 provides an overview of the 4 general cardiac-disease measures used in research and in the clinical setting. The intent of this article is to provide a concise review of a lately developed QOL tool for heart failure, the Kansas City Cardiomyopathy Questionnaire (KCCQ) This article will provide an overview of the tool's disentanglement the methods to administer and interpret the tool, as well as the psychometric properties of the measure.

ADMINISTRATION

The KCCQ was lay opened with information obtained from an extensive literature review, examination of available instruments, and discussion with focus collections of patients with heart failure. progression in a continuously ascending gradation of the tool was initiated from Dr. John Spertus, of Cardiovascular issues Inc., with psychometric testing typeed after the testing of the Seattle Angina Questionnaire.' From this initial testing, the KCCQ emerg as a self-administered, 23-item questionnaire that quantifies physical limitations, symptoms, self-efficacy, social interference, and quality of life (Appendix 1)3 This tool requires 4 to 6 minutes to finished and contains 8 domains including physical symptoms, symptoms stability, social limitation, self-efficacy, quality of life, functional status, and clinical summary. replications to the 23 questions are based forward a 5-point Likert scale, ranging from 'extremely limited' to 'not at all limited/ Each answer corresponds to an ordinal value, ranging from 1 to 5 with the ability to calculate a total score as well as a score for each of the 8 domains. The total score can range from O to 100 with a higher score indicative of better health status. A functional status score can be calculated through combining the physical and symptom domains. A clinical summary score can be calculated by means of combining the functional status score, QOL domain, and social limitation domains. A clinically important change in the total score of the KCCQ is defined as greater than or equal to 5 points.4 To obtain scoring algorithms and licensing information, the reader is referr to www.cvoutcomes.org for further information.

PSYCHOMETRIC PROPERTIES

Initial validity and reliability of the tool was assessed in a sample of 70 stable and 59 decompensated heart failure patients with an ejection fraction of les than 40% as determined by means of nuclear imaging, echocardiogram, or left ventriculogram. Test-retest reliability was assessed using a cohort of 39 patients with stable heart failure who were administered the questionnaire at baseline and after 3 month Internal consistency, assessed with Cronbach's alpha, was greater than the acceptable value of 80 reject for self-efficacy, which was build to be 0.62. Test-retest reliability was assessed using a student's t-test with no statistically significant differences construct from the baseline assessment.3